Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal

Experimental Cell Research

Volumn 290, Issue 1, 2003, Pages 93-107

  Alldridge, Louise C ^a   Bryant, Clare E ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Actin; Annexin 1; Cytoskeleton; ERK; Proliferation; Signal transduction

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; LIPOCORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN P21;

ACTIN FILAMENT; ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL DISRUPTION; CELL PROLIFERATION; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INDUCTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; KIDNEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0141680604     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4827(03)00310-0     Document Type: Article

References (90)

1. Raynal P., Pollard H.B. Annexins the problem of assesing the biological role for multi-functional calcium- and phospholipid-binding proteins . Biochim. Biophys. Acta. 1197:1994;63-93.
2. Mollenbauer J., Morgan R.O., Fernandez M.-P., Liemann S., Huber R., Rothhut B., Reutelingsperger C.P.M., Donnelly W.L., Moss S.E., von der Mark K., Delmer D.P., Potikha T.S., Bastian B.C. Annexins (multi-author eview). Cell. Mol. Life Sci. 53:1997;506-556.
3. Crompton M.R., Moss S.E., S.E., Crumpton M.J., Diversity in the lipocortin/calpactin family. Cell 55 (1998) 1-3.
4. Moss S. Annexins taken to task. Nature. 378:1995;446-447.
5. Flower R.J., Rothwell N.J. Lipocortin 1 cellular mechanisms and clinical relevance . Trends Pharmacol. Sci. 15:1994;71-76.
6. Diakanova M., Gerke V., Ernst J., Liautard J.-P., van der Vusse G., Griffiths G. Localisation of five annexins in J774 macrophages and isolated phagosomes. J. Cell Sci. 110:1997;1199-1213.
7. Alldridge L.C., Harris H.J., Plevin R., Hannon R., Bryant C.E. Regulation of the mitogen activated protein kinase/ERK pathway by the annexin lipocortin 1. J. Biol. Chem. 274:1999;37620-37628.
8. Croxtall J.C., Choudary Q., Flower R. Glucocorticoids act within minutes to inhibit recruitment of signalling factors to activated EGF receptors through a receptor-dependent and transcription independent mechanism. Br. J. Pharmacol. 130:2000;289-298.
9. Sawyer S.T., Cohen S. Epidermal growth factor stimulates the phosphorylation of the calcium dependent 35,000-Dalton substrate in intact A-431 cells. J. Biol. Chem. 260:1985;8233-8236.
10. Almawi W.Y., Lipman M.L., Stevens A.C., Zanker B., Hadro E.T., Strom T.B. Abrogation of glucocorticoid-mediated inhibition of T-cell proliferation by the synergistic action of IL-1, IL-6 and IFNγ J. Immunol. 146:1991;3523-3529.
11. Skouteris G.C., Schroder C.H. The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin 1 transduces the proliferation signal of the hepatocyte growth factor. J. Biol. Chem. 271:1996;27266-27273.
12. Almawi W.Y., Saouda M.S., Stevens A.C., Lipman M.L., Barth C.B., Storm T.R. Partial mediation of glucocorticoid antiproliferative effects by Lipocortins. J. Immunol. 157:1996;5231-5239.
13. Salles J.P., Netelenbos J.C., Slootweg M.C. Growth hormone induces tyrosine phosphorylation of annexin-1 in rat osteosarcoma cells. Endocrinology. 137:1996;4358-4362.
14. Croxtall J.D., Choudhury Q., Flower R.J. Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachiodonic acid release and proliferation in the A549 cell line identificationof E-Q-E-Y-V as a crucial component . Br. J. Pharmacol. 123:1998;975-983.
15. Schlaepfer D.D., Haigler H.T. Expression of annexins as a function of cellular growth state. J. Cell Biol. 111:1990;229-238.
16. Solito E., de Coupade C., Parente L., Flower R.J., Russo-Marie F. Human annexin 1 is highly expressed during the differentiation of epithelial cell line A 549 involvement of nuclear factor interleukin 6 in phorbol ester induction of annexin 1 . Cell Growth Differ. 4:1998;327-336.
17. Spenneberg R., Osterloh D., Gerke V. Phospholipid vesicle binding and aggregation by four novel fish annexins are differentially regulated by calcium. Biochim. Biophys. Acta. 1448:1998;311-319.
18. Chepenik K.P., Shipman-Appasamy P., Ahn N., Goldowitz D. Developmental regulation of various annexins in the embryonic palate of the mouse. J. Craniofacial Genet. Dev. Biol. 15:1995;171-181.
19. Fava R.A., Nanney L.B., Wilson D., King L.E. Jr. Annexin 1 localisation in the human skin possible association with cytoskeletal elements in keratinocytes of the stratum spinosum . J. Invest. Dermatol. 101:1993;732-737.
20. Xin W., Rhodes D.R., Ingold C., Chinnaiyan A.M., Rubin M.A. Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am. J. Pathol. 162:2003;255-261.
21. Paweletz C.P., Ornstein D.K., Roth M.J., Bichsel V.E., Gillespie J.W., Calvert V.S., Vocke C.D., Hewitt S.M., Duray P.H., Herring .J., Wang Q.H., Hu .N., Linehan W.M., Taylor P.R., Liotta L.A., Emmert-Buck M.R., Petricoin E.F. Loss of annexin 1 correlates with early onset of tumorigenesis in esophageal and prostate carcinoma. Cancer Res. 60:2000;6293-6297.
22. Croxtal J.D., Flower R. Lipocortin-1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA. 89:1992;3571-3575.
23. Rothhut B. Participation of annexins in protein phosphorylation. Cell. Mol. Life Sci. 53:1997;522-526.
24. Karasik A., Pepinsky R.B., Shoelson S.E., Katin C.R. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J. Biol. Chem. 263:1988;11862-11867.
25. Salles J.P., Gayral-Taminh M., Fauvel J., Delobbe I., Mignon-Conte M., Conte J.J., Chap H. Lipocortins 1 and 2 as substrates for the insulin receptor kinase in rat liver. J. Biol. Chem. 268:1993;12805-12811.
26. Raynal P., Pollard H.B., Srivastrava M. Cell cycle and post-transcriptional regulation of annexin expression in IMR-90 human fibroblasts. Biochem. J. 322:1997;365-372.
27. Rescan C., Coutant A., Talarmin H., Theret N., Glaise D., Guguen-Guillouzo C., Baffet G. Mechanism in the sequential control of cell morphology and S-phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol. Cell. Biol. 12:2001;725-738.
28. Marshall C.J. Specificity of receptor tyrosine kinase signalling transient versus sustained extracellular signal-regulated kinase activation . Cell. 80:1995;179-185.
29. cip1. Mol. Cell. Biol. 17:1997;5598-5611.
30. Pumiglia K., Decker S. Cell cycle arrest mediated by the MEK/mitogen activated protein kinase pathway. Proc. Natl. Acad. Sci. USA. 94:1997;448-452.
31. Balmanno K., Cook S.J. Sustained MAP kinase activation is required for the expression of cyclin D1, p21cip1 and a subset of AP1 proteins in CCL39 cells. Oncogene. 18:1999;3085-3097.
32. Davis R.J. The mitogen activated protein kinase signal transduction pathway. J. Biol. Chem. 268:1993;14553-14556.
33. Murphy, L.O., Smith S., Chen R.-H., Finger D.C., John Blenis. Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4 (2002) 556-564.
34. Roovers K., Assoian R.K. Integrating the MAP kinase signal into the G1 phase cell cycle machinery. Bioessays. 22:2000;818-826.
35. Oh J., Rhee H.J., Kim S.-W., Kim S.B., You H.-J., Kim J.H., Na D.S. Annexin-1 inhibits PMA-induced c-fos SRE activation by suppressing cytosolic phospholipase A2 signal. FEBS Lett. 477:2000;244-248.
36. Rane M.J., Arthur J.M., Prossnitz E.R., McLeish K.R. Activation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail. J. Biol. Chem. 273:1998;20916-20923.
37. Lopez J.P., Manriquez E., delaFuente M. The actin binding site in annexin-1. Biophys. J. 74:1998;A24.
38. Hyun Y.-L., Park Y.M., Na D.S. ATP and GTP hydrolytic function of N-terminally deleted annexin I. J. Biochem. Mol. Biol. 33:2000;289-293.
39. Stewers L., Yelon D., Berg L., Chant J. Regulation of polarisation of T-cells towards antigen presenting cells by Ras related GTPase cdc42. Proc. Natl. Acad. Sci. USA. 92:1995;5027-5031.
40. Perretti M., Flower R. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1. J. Immunol. 150:1993;992-999.
41. Wu, C.-C., Croxtall J., Perretti M., Bryant C., Thiemermann C., Flower R., Vane, J. Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat. Proc. Natl. Acad. Sci. USA. 92:1995;3473-3477.
42. Bryant C.E., Perretti M., Flower R.J. Suppression by dexamethasone of inducible nitric oxide synthase protein expression in vivo a possible role for Lipocortin 1 . Biochem. Pharmacol. 55:1998;279-285.
43. Nakayasu H., Berezney R. Mapping replication sites in the eukaryotic cell nucleus. J. Cell Biol. 108:1989;1-11.
44. Dimuthu R. DeSilva, Elizabeth A. Jones, Margaret Favata, F. Bruce D. Jaffee, Ronald L. Magolda, James M. Trzaskos, and Peggy A. Scherle, Inhibition of mitogen-activated protein kinase kinase blocks T cell proliferation but does not induce or prevent anergy. J. Immunol. 160 (1998) 4175-4181.
45. Canaider S., Solito E., de Coupade C., Flower R.J., Russo-Marie F., Goulding N.J., Perretti M. Increased apoptosis in U937 cells over-expressing lipocortin 1. Life Sci. 6:2000;265-270.
46. Erhardt P., Schremser E.J., Cooper G.M. B-raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/ERK pathway. Mol. Cell. Biol. 19:1999;5308-5315.
47. Russo-Marie F., Duval D. Dexamethasone-induced inhibition of prostaglandin production does not result from a direct action on phospholipase activation but is mediated through a steroid induced factor. Biochim. Biophys. Acta. 712:1982;177-185.
48. Grove R.I., Willis W.D., Pratt M. Inhibition of arachiodonic acid metabolism is not involved on dexamethasone-induced growth inhibition in embryonic palatal development. Prostaglandins Leukotrines Med. 17:1985;85-95.
49. Almawi W.Y., Lipman M.L., Stevens A.C., Zanker B., Hadro E.T., Strom T.B. Abrogation of glucocorticoid-mediated inhibition of T-cell proliferation by the synergistic action of IL-1, IL-6 and IFNγ J. Immunol. 146:1991;3523-3529.
50. Mansour S., Matten W., Hermann A., Candida J., Rong S., Fukaswa K., Vande Woude G., Ahn N. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:1994;966-970.
51. Morishima M., Kosik K.S. The pool of MAP kinase associated with microtubules is small but constitutively active. Mol. Cell. Biol. 7:1996;893-905.
52. Bourgin C., Bourette R., Mouchiroud G., Arnaud S. Expression of MONA (monocyte adapter) in myeloid progenitor cells reslts in increased and prolonged MAP kinase activation upon macrophage colony-stimulating factor stimulation. FEBS Lett. 480:2000;113-117.
53. Harada T., Morooka T., Ogawa S., Nishida E. ERK inducescp35, a neuron-specific activator of Cdk5, through induction of Egrl. Nat. Cell Biol. 3:2001;453-459.
54. Matsumara I., Nakajima K., Wakao H., Hattori S., Hashimoto K., Sugahara H., Kato T., Miyazaki H., Hirano T., Kanakura Y. Involvement of prolonged Ras activation in thrombopoetin-induced megakaryocyte differentiation of a human factor-dependent hematopoietic cell line. Mol. Cell. Biol. 18:1998;4282-4290.
55. Black E.J., Clark W., Gillespie D.A.F. Transient deactivation of ERK signalling is sufficient for stable entry into G0 in primary avian fibroblasts. Curr. Biol. 10:2000;1119-1122.
56. Bottazzi M.E., Zhu X., Bohmer R.M., Assoian R.K. Regulation of p21/cip1 expression by growth factors and extracellular matrix reveals a role for transient ERK activity in G1 phase. J. Cell. Biol. 146:1999;1255-1264.
57. Sewing A., Wiseman B., Lloyd A.C., Land H. High intensity Raf signal causes cell cycle arrest mediated by p21/cip. Mol. Cell. Biol. 17:1997;5588-5597.
58. Lui Y., Martindale J.L., Goroscope M., Holbrook N.J. Regulation of p21/cip1 waf1 expression through mitogen-activated protein kinase signalling pathway. Cancer Res. 56:1996;31-35.
59. Buscher D., Hipskind R.A., Krautwald S., Reimann T., Baccarini M. Ras-dependent and independent pathways target the mitogen activated protein kinase network in macrophages. Mol. Cell. Biol. 15:1995;466-475.
60. Buscher D., Dello Sparba P., Hipskind R.A., Rapp U.R., Stanley E.R., Baccarini M. vRaf confers CSF-independent growth to a macrophage cell line and leads to immediate early gene ecpression without MAPK activation. Oncogene. 8:1993;3323-3332.
61. Gallego C., Gupta S.K., Heasley L.E., Qian N.X., Johnson G.L. Mitogen-activated protein kinase activation resulting from selective oncogene expression in NIH 3T3 and rat Ia cells. Proc. Natl. Acad. Sci. USA. 89:1992;7355-7359.
62. Wood K.W., Qi H., D'Arcangelo G., Armstrong R.C., Roberts T.M., Haleouga S. The cytoplasmic raf oncogene induces a neuronal phenotype in PC12 cell a potential role for cellular raf kinases in neuronal growth factor signal transduction . Proc. Natl. Acad. Sci. USA. 90:1993;5016-5020.
63. Chao T.S., Byron K.M., Lee K.M., Villereal M., Rosner M.R. Differential Raf requirement for activation of mitogen-activated protein kinase by growth factors, phorbal esters and calcium. J. Biol. Chem. 267:1994;7337-7341.
64. Langercarter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., Johnson G.L. A divergence in the MAP kinase regulatory network defined by MEK kinase and raf. Science. 260:1993;315-319.
65. Huser M., Luckett J., Chiloeches A., Mercer K., Iwobi M., Gilbert S., Sun X.-M., Brown J., Marias R., Pritchard C. MEK kinase activity is not necessary for Raf-1 function. EMBO. J. 20:2001;1940-1951.
66. Rozakis-Adcock M., Fernley R., Wade J., Pawson T., Bowtell D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the RAS activator MSOS1. Nature. 363:1993;83-85.
67. Curto M., Frankel P., Carrero A., Foster D.A. Novel recruitment of Shc, Grb-2 and Sos by FGFR-1 in v-src transformed cells. Biochem. Biophys. Res. Commun. 243:1998;555-560.
68. Leof E.B. Growth factor receptor signalling location, location, location . Trends Cell Biol. 10:2000;343-348.
69. Teruel M.N., Meyer T. Translocation and reversible localization of signalling proteins a dynamic future for signal transduction . Cell. 103:2000;181-184.
70. Glading A., Uberall F., Keyse S.M., Lauffenburger D.A., Wells A. Membrane proximal ERK receptor signalling is required for M-calpain activation downstream of epidermal growth factor receptor signalling. J. Biol. Chem. (2001) 23341-23348.
71. Traverso V., Morris J., Flower R., Buckingham J. Lipocortin 1 (annexin 1) in patches associated with the membrane of a lung adenocarcinoma cell line and in the cytoplasm. J. Cell Sci. 111:1998;1405-1418.
72. Goulding N.J., Pan L., Wardell K., Guyre V.C., Guyre P.M. Evidence for specific annexin-1 binding proteins on human monocytes. Biochem. J. 316:1996;593-597.
73. Parent C.A., Devreotes P.N. A cells sense of direction. Science. 284:1999;765-770.
74. Bell B., Xing H., Yan K., Gautam N., Muslim A.J. KSR-1 binds to G-protein betagamma subunits and inhibits betagamma induced mitogen-activated protein kinase. J. Biol. Chem. 274:1999;7982-7986.
75. Gotoh I., Fukunda M., Adachi M., Nishida E. Control of the cell morphology and the S-phase entry by mitogen-activated protein kinase kinase. J. Biol. Chem. 274:1999;11874-11880.
76. Haung S., Chen C.S., Ingber D.E. Control of cyclin D1, p27/kip1, and cell cycle progression in human capillary endothelium cells by cell shape and cytoskeletal tension. Mol. Biol. Cell. 9:1998;3179-3193.
77. Sahai E., Olson M.F., Marshall C.J. Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J. 20:2001;755-766.
78. Mansfield P.J., Shayman J.A., Boxer L.A. Regulation of polymorphonuclear leukocyte phagocytosis by myosin light chain kinase after activation of mitogen-activated protein kinase. Blood. 95:2000;2407-2412.
79. Stewers L., Yelon D., Berg L., Chant J. Regulation of polarisation of T-cells towards antigen presenting cells by Ras related GTPase cdc42. Proc. Natl. Acad. Sci. USA. 92:1995;5027-5031.
80. Rusanescu G., Gotoh T., Tian X., Fieg L.A. Regulation of Ras signalling specificity by protein kinase C. Mol. Cell. Biol. 21:2001;2650-2658.
81. Atabey N., Goa Y., Yao Z.-J., Breckenridge D., Soon L., Soriano J.V., Burke T.R. Jr, Bottaro D.P. Potent blockade of hepatocyte growth factor-stimulated cell motility, matrix invasion and branching morphogenesis by antagonists of Grb-2 src homology domain interactions. J. Biol. Chem. 276:2001;14308-14314.
82. John P.C., Mews M., Moore R. Cyclin/Cdk complexes their involvement in cell cycle progression and mitotic division . Protoplasma. 216:2001;119-142.
83. Iwamoto H., Nakamuta M., Tada S., Sugimoto R., Enjoji M., Nawata H. A p160ROCK-specific inhibitor, Y-27632, attenuates rat hepatic stellate cell growth. J. Hepatol. 32:2000;762-770.
84. Fasshauer M., Iwig M., Glaesser D. Synthesis of proto-oncogene proteins and cyclins depends on intact microfilaments. Eur. J. Cell Biol. 77:1998;188-195.
85. Huang S., Chen C.S., Ingber D.E. Control of cyclin D1, p27(Kip1), and cell cycle progression in human capillary endothelial cells by cell shape and cytoskeletal tension. Mol. Cell. Biol. 11:1998;3179-3193.
86. Texiera A., Chaverot N., Strosberg A.D., Cazaubon S. Differential regulation of cyclin D1 and D3 expression in the control of astrocyte proliferation induced by endothelin-1. J. Neurochem. 74:2000;1034-1040.
87. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. USA. 96:1999;5522-5527.
88. Bottazzi M.E., Buzzai M., Zhu X., Desdouets C., Brechot C., Assoian R.K. Distinct effects of mitogens and the actin cytoskeleton on CREB and pocket protein phosphorylation control the extent and timing of cyclin A promotor activity. Mol. Cell. Biol. 22:2001;7607-7616.
89. Aplin A.E., Stewart S.A., Assoian R.K., Juliano R.L. Integrin mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J. Cell Biol. 153:2001;273-282.
90. Ingber D.E. Tensegrity II. How structural networks influence cellular information processing networks. J. Cell Sci. 166:2003;1397-1408.